|
BMI
|
30.1 ± 6.3
|
26.7 ± 5.6
|
<0.0001
|
|
Overweight (BMI 25–30)
|
871 (30.6 %)
|
4,608 (33.0 %)
|
0.0128
|
|
Obese (BMI > =30)
|
1,333 (46.9 %)
|
3,427 (24.6 %)
|
<0.0001
|
|
Chronic obstructive pulmonary disease
|
29 (1.2 %)
|
164 (1.4 %)
|
0.47
|
|
Medically-treated hypertension
|
574 (23.4 %)
|
2,062 (17.2 %)
|
<0.0001
|
|
Coronary artery disease
|
76 (3.1 %)
|
184 (1.5 %)
|
<0.0001
|
|
Stroke
|
21 (0.8 %)
|
77 (0.6 %)
|
0.24
|
|
Peripheral vascular disease
|
24 (1.0 %)
|
108 (0.9 %)
|
0.73
|
|
Pulmonary embolism
|
8 (0.3 %)
|
45 (0.4 %)
|
0.72
|
|
Malignancy (solid organ or lymphoproliferative)
|
210 (7.2 %)
|
1,544 (10.9 %)
|
<0.0001
|
|
Other solid organ transplants
|
7 (0.2 %)
|
106 (0.7 %)
|
0.0022
|
|
Primary liver malignancy
|
130 (4.5 %)
|
2,202 (15.4 %)
|
<0.0001
|
|
TIPSS
|
300 (10.4 %)
|
1,073 (7.6 %)
|
<0.0001
|
|
Transplantation
| | | |
|
Last MELD score
|
22.8 ± 8.5
|
22.2 ± 9.9
|
<0.0001
|
|
Heterotopic transplant
|
3 (0.1 %)
|
15 (0.1 %)
|
0.97
|
|
Transplant from a living donor
|
97 (3.3 %)
|
729 (5.1 %)
|
<0.0001
|
|
Donor’s age
|
43.2 ± 17.4
|
41.4 ± 17.6
|
<0.0001
|
|
Donor’s history of DM
|
315 (11.2 %)
|
1,357 (10.1 %)
|
0.06
|
|
Procurement from a non-heart beating donor
|
137 (4.9 %)
|
572 (4.2 %)
|
0.13
|
|
Number of HLA mismatches with a donor
|
4.52 ± 1.15
|
4.55 ± 1.14
|
0.39
|
|
Immunosuppressants used at transplant:
| | | |
|
Mycophenolates
|
2,275 (78.2 %)
|
10,943 (76.9 %)
|
0.14
|
|
Tacrolimus
|
2,695 (92.6 %)
|
13,235 (93.0 %)
|
0.43
|
|
Steroids
|
2,763 (94.9 %)
|
13,519 (95.0 %)
|
0.88
|
|
Rejection episode before discharge
|
166 (6.2 %)
|
999 (7.8 %)
|
0.0031
|
|
Post-transplant inpatient stay, days
|
16.0 ± 18.7
|
15.6 ± 19.9
|
0.0498
|
|
Total inpatient stay, days
|
20.7 ± 36.2
|
20.1 ± 29.2
|
0.16
|
|
Non-compliant in follow-up (ever)
|
104 (4.0 %)
|
764 (6.0 %)
|
0.0001
|
